ITRM
NASDAQ · Pharmaceuticals
Iterum Therapeutics Plc
$0.04
+0.01 (+30.67%)
Open$0.01
Previous Close$0.03
Day High$0.05
Day Low$0.01
52W High$1.28
52W Low—
Volume—
Avg Volume242.7K
Market Cap1.02M
P/E Ratio—
EPS$-0.75
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+61,175.5% upside
Current
$0.04
$0.04
Target
$24.02
$24.02
$15.49
$24.02 avg
$28.73
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.84M | 2.52M | 2.36M |
| Net Income | 737.1K | 595.8K | 463.7K |
| Profit Margin | 25.9% | 23.7% | 19.6% |
| EBITDA | 1.27M | 1.08M | 1.08M |
| Free Cash Flow | 617.3K | 603.4K | 596.2K |
| Rev Growth | +5.6% | +6.9% | +16.3% |
| Debt/Equity | 0.35 | 0.29 | 0.29 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |